Head to Head Comparison of Two Needles EUS Guided FNB
Withdrawn before enrolling · Not applicable
Conditions studied: Pancreatic Tumor
In brief
The aim of this study is to evaluate and compare the diagnostic accuracy and specimen adequacy of two ultrasound biopsy needles. These are two existing FDA approved tissue biopsy regimens, with respect to diagnosis of solid pancreatic lesions.
Key facts
- Study ID
- NCT02534246
- Run by
- Milton S. Hershey Medical Center
- People needed
- 0
- Starts
- 2016-08-01
- Expected to finish
- 2017-10-01
- Last updated by the study team
- 2016-09-13
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult subjects aged 18-90 of any gender, ethnicity and race that are referred to endoscopy for endoscopic ultrasound guided tissue acquisition for solid pancreatic mass.
- Voluntary enrollment
- Ability to give written informed consent
- Subjects must have a pancreatic mass detected by radiology (CT or MRI) or ultrasound or at the time of EUS.
You may not qualify if…
- Patients with coagulopathy with an elevated INR>2
- Any individual who cannot provide one's voluntary informed written consent.
- Any pre-existing or discovered medical condition that may at the discretion of investigator interfere with the completion of and/ or participation in existing protocol.
- Pregnancy
- Less than 18 years old
Where it is running
- Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.